These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37820607)

  • 1. Simple Scoring System for Esophagogastric Varices Prediction in Hepatocellular Carcinoma Patients without Liver Stiffness Evaluation.
    Hiraoka A; Tada F; Ohama H; Fukumoto M; Matsuoka K; Matsuda T; Nakatani K; Yanagihara E; Saneto H; Izumoto H; Murakami T; Onishi K; Kitahata S; Kanemitsu-Okada K; Kawamura T; Kuroda T; Miyata H; Tsubouchi E; Hirooka M; Abe M; Matsuura B; Ninomiya T; Hiasa Y
    Oncology; 2024; 102(4):291-298. PubMed ID: 37820607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical predictors of large esophagogastric varices in patients with hepatocellular carcinoma.
    Yeh JL; Peng YC; Tung CF; Chen GH; Chow WK; Chang CS; Yeh HZ; Poon SK
    Dig Dis Sci; 2002 Apr; 47(4):723-9. PubMed ID: 11991599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of shear wave elastography for predicting hepatocellular carcinoma and esophagogastric varices in patients with chronic liver disease.
    Kasai Y; Moriyasu F; Saito K; Hara T; Kobayashi Y; Nakamura I; Sugimoto K
    J Med Ultrason (2001); 2015 Jul; 42(3):349-55. PubMed ID: 26576786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between esophagogastric varices in hepatocellular carcinoma and poor prognosis after transarterial chemoembolization: A propensity score matching analysis.
    Su CW; Fang KC; Lee RC; Liu CA; Chen PH; Lee PC; Kao WY; Huang YH; Huo TI; Hou MC; Lin HC; Wu JC
    J Formos Med Assoc; 2020 Feb; 119(2):610-620. PubMed ID: 31542334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Modified ALBI Grade With Endoscopic Findings of Gastroesophageal Varices.
    Miyamoto Y; Enomoto H; Nishikawa H; Nishimura T; Iwata Y; Nishiguchi S; Iijima H
    In Vivo; 2021; 35(2):1163-1168. PubMed ID: 33622916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma.
    Hsieh WY; Chen PH; Lin IY; Su CW; Chao Y; Huo TI; Huang YH; Hou MC; Lin HC; Wu JC
    Sci Rep; 2017 Feb; 7():42577. PubMed ID: 28209963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of oesophagogastric varices in patients with liver cirrhosis.
    Ng FH; Wong SY; Loo CK; Lam KM; Lai CW; Cheng CS
    J Gastroenterol Hepatol; 1999 Aug; 14(8):785-90. PubMed ID: 10482429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of Screening for Esophagogastric Varices in Naïve Hepatocellular Carcinoma Patients within Milan Criteria: Indicator for Liver Transplantation.
    Kawakami T; Hiraoka A; Michitaka K; Ninomiya T; Hirooka M; Hiasa Y
    Dig Surg; 2017; 34(5):429-435. PubMed ID: 28196353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram model for predicting esophsagogastric varices in hepatocellular carcinoma with cirrhosis.
    Zhang D; Deng J; Guo X; Zheng Y; Xu X
    Eur J Gastroenterol Hepatol; 2023 Mar; 35(3):342-348. PubMed ID: 36708306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baveno VII criteria identify varices needing treatment in patients with hepatocellular carcinoma of different Barcelona Clinic Liver Cancer stages.
    Wu CW; Wong GL; Wong VW; Yam TF; Yip TC; Wong AC; Chan BW; Fong MM; Lai JC; Tse YK; Lee KF; Mok TS; Chan HL; Lui RN; Chan SL; Ng KK
    J Gastroenterol Hepatol; 2023 Aug; 38(8):1381-1388. PubMed ID: 37218373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver and spleen stiffness on ultrasound elastography are predictors of the occurrence of esophagogastric varices after balloon-occluded retrograde transvenous obliteration.
    Furuichi Y; Abe M; Yoshimasu Y; Takeuchi H; Itoi T
    J Hepatobiliary Pancreat Sci; 2022 Jun; 29(6):713-722. PubMed ID: 35301809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
    Maurice JB; Brodkin E; Arnold F; Navaratnam A; Paine H; Khawar S; Dhar A; Patch D; O'Beirne J; Mookerjee R; Pinzani M; Tsochatzis E; Westbrook RH
    J Hepatol; 2016 Nov; 65(5):899-905. PubMed ID: 27388923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive model for predicting high-risk esophageal varices based on liver and spleen stiffness.
    Yang LB; Gao X; Li H; Tantai XX; Chen FR; Dong L; Dang XS; Wei ZC; Liu CY; Wang Y
    World J Gastroenterol; 2023 Jul; 29(25):4072-4084. PubMed ID: 37476583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma.
    Allaire M; Campion B; Demory A; Larrey E; Wagner M; Rudler M; Roux C; Blaise L; Carrie NG; Thabut D
    Aliment Pharmacol Ther; 2023 Aug; 58(3):346-356. PubMed ID: 37300315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in Lenvatinib.
    Iavarone M; Alimenti E; Tada T; Shimose S; Suda G; Yoo C; Soldà C; Piscaglia F; Tosetti G; Marra F; Vivaldi C; Conti F; Schirripa M; Iwamoto H; Sho T; Lee SH; Rizzato MD; Tonnini M; Rimini M; Campani C; Masi G; Foschi F; Bruccoleri M; Kawaguchi T; Kumada T; Hiraoka A; Atsukawa M; Fukunishi S; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Hatanaka T; Kakizaki S; Kawata K; Tada F; Ohama H; Itokawa N; Okubo T; Arai T; Imai M; Naganuma A; Casadei-Gardini A; Lampertico P
    Liver Cancer; 2024 Apr; 13(2):215-226. PubMed ID: 38751557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
    Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
    J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varices.
    Chen PH; Hsieh WY; Su CW; Hou MC; Wang YP; Hsin IF; Yang TC; Liao WC; Lin HC; Lee FY; Wu JC
    Gastrointest Endosc; 2018 Aug; 88(2):230-239.e2. PubMed ID: 29317268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients.
    Kikukawa K; Uchida-Kobayashi S; Tamori A; Yoshida K; Kotani K; Motoyama H; Kozuka R; Hagihara A; Fujii H; Morikawa H; Enomoto M; Murakami Y; Kawada N
    Ann Hepatol; 2020; 19(4):367-372. PubMed ID: 32444247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does transient elastography (FibroScan®) have a role in decision making in hepatocellular carcinoma?
    Pesce A; Scilletta R; Branca A; Nigro L; Montineri A; Larocca L; Fatuzzo F; Castaing M; Puleo S
    HPB (Oxford); 2012 Jun; 14(6):403-8. PubMed ID: 22568417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis.
    Calvaruso V; Bronte F; Conte E; Simone F; Craxì A; Di Marco V
    J Viral Hepat; 2013 Dec; 20(12):867-74. PubMed ID: 24304456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.